Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events.

about

Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events.

Item

http://www.wikidata.org/entity/Q55014809

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Anticoagulation and antiplatel ...... Charybdis of ischaemic events.

@en

Anticoagulation and antiplatel ...... Charybdis of ischaemic events.

@nl

type

Item

label

Anticoagulation and antiplatel ...... Charybdis of ischaemic events.

@en

Anticoagulation and antiplatel ...... Charybdis of ischaemic events.

@nl

prefLabel

Anticoagulation and antiplatel ...... Charybdis of ischaemic events.

@en

Anticoagulation and antiplatel ...... Charybdis of ischaemic events.

@nl

P1476

Anticoagulation and antiplatel ...... Charybdis of ischaemic events.

@en

P2093

R J de Winter

http://www.w3.org/2001/XMLSchema#string

P2860

Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.

Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.

Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart

Selection of P2Y12 inhibitor in percutaneous coronary intervention and/or acute coronary syndrome.

Optimal pharmacological therapy in ST-elevation myocardial infarction-a review : A review of antithrombotic therapies in STEMI.

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management.

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation.

A practical guide on how to handle patients with bleeding events while on oral antithrombotic treatment.

Optimal treatment of patients with NSTE-ACS in the Dutch health care system.

Optimal duration of dual antiplatelet therapy for coronary artery disease.

P2888

s12471-018-1121-5

P304

287-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S12471-018-1121-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104169966

http://www.w3.org/2001/XMLSchema#string

P698

29797236

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

5968008

http://www.w3.org/2001/XMLSchema#string